his best bet is

来源: jaydad 于 2013-01-13 20:27:55 [] [博客] [旧帖] [给我悄悄话] 阅读数 : (298 bytes)
回答: 急性淋巴细胞性白血病请教 由 xinxinren 于 2013-01-13 15:24:34

ponatinib, or Iclusig, formally known as AP24534 in clinical trials, made by a Boston-based company Ariad Pharmaceuticals, Inc. 

Iclusig was approved by FDA about a month ago, for treatment of AML and Ph+ ALL that can no longer be controlled by Gleevac and chemotherapies. 

所有跟帖： 

• should also mention -jaydad- ♂ 给 jaydad 发送悄悄话 jaydad 的博客首页 (434 bytes) () 01/13/2013 postreply 21:14:13

• Thank you so much, that is good news! but -xinxinren- ♀ 给 xinxinren 发送悄悄话 (90 bytes) () 01/14/2013 postreply 11:50:24

请您先登陆，再发跟帖！